文献速递细菌感染、耐药与抗菌药物

重新部署β-内酰胺类抗生素作为抗毒力策略治疗耐甲氧西林金黄色葡萄球菌感染

Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
PubMed 文献 · J Infect Dis · 2016-11-14

该研究探讨利用现有抗生素的新策略以应对耐药危机。通过体外机制实验及侵袭性肺炎和脓毒症体内模型,发现尽管MRSA对苯唑西林耐药,但苯唑西林可显著减弱MRSA毒力,主要基于对 agr 群体感应系统的抑制和细胞壁结构改变,从而增加宿主对MRSA的清除。数据提示β-内酰胺类抗生素应作为辅助抗毒力疗法纳入MRSA感染治疗方案。

要点

  • 苯唑西林可显著减弱MRSA毒力,尽管MRSA对该药耐药。
  • 机制涉及苯唑西林依赖性抑制 agr 群体感应系统及改变细胞壁结构。
  • β-内酰胺类抗生素可考虑作为辅助抗毒力疗法用于MRSA感染。

核心结论

  • 苯唑西林可显著减弱MRSA毒力,尽管病原体对该药耐药。
  • β-内酰胺类抗生素应作为辅助抗毒力疗法纳入MRSA感染治疗方案。

研究设计与样本

  • 采用体外机制实验及侵袭性肺炎和脓毒症体内模型。

主要发现

  • 苯唑西林处理的MRSA菌株毒力显著减弱。
  • 该效应主要基于苯唑西林依赖性抑制 agr 群体感应系统及改变细胞壁结构。
  • 上述改变导致MRSA对宿主杀伤的易感性增加。

临床怎么用

  • MRSA感染患者的治疗方案中可考虑纳入β-内酰胺类抗生素作为辅助抗毒力治疗。
  • 该策略可能代表对当前MRSA感染临床实践的重要改变,有望以安全、经济的方式改善患者结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Innovative approaches to the use of existing antibiotics is an important strategy in efforts to address the escalating antimicrobial resistance crisis. We report a new approach to the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections by demonstrating that oxacillin can be used to significantly attenuate the virulence of MRSA despite the pathogen being resistant to this drug. Using mechanistic in vitro assays and in vivo models of invasive pneumonia and sepsis, we show that oxacillin-treated MRSA strains are significantly attenuated in virulence. This effect is based primarily on the oxacillin-dependent repression of the accessory gene regulator quorum-sensing system and altered cell wall architecture, which in turn lead to increased susceptibility to host killing of MRSA. Our data indicate that β-lactam antibiotics should be included in the treatment regimen as an adjunct antivirulence therapy for patients with MRSA infections. This would represent an important change to current clinical practice for treatment of MRSA infection, with the potential to significantly improve patient outcomes in a safe, cost-effective manner.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Waters EM, Rudkin JK, Coughlan S, et al. Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. J Infect Dis. 2016. PMID: 28077586. doi:10.1093/infdis/jiw461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。